Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Technological University Dublin is active in the Biotechnology & Pharmaceuticals technology area with 2 pending office actions. These 2 pending office actions are distributed across 2 distinct art units, which suggests that the current patent applications involve different technical sub-specialties. Practitioners must be prepared to navigate the different examination cultures and procedural requirements of the 2 distinct art units. The success of the 2 pending office actions depends on addressing the specific technical standards and precedents prevalent in each of these units.
The prosecution effort involves 2 distinct examiners, meaning that each pending matter is reviewed by a different official. GONZALEZ, LUISALBERTO is the busiest examiner for the portfolio and is responsible for 1 pending office action. With 2 distinct examiners managing the 2 pending office actions, there is no centralization of the examination process at the individual level. This fragmentation requires practitioners to tailor their advocacy to the specific preferences of GONZALEZ, LUISALBERTO and the other assigned examiner. Effectively managing the 2 pending office actions requires a high degree of coordination across the 2 distinct art units to resolve the 1 pending office action assigned to the busiest examiner.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GONZALEZ, LUISALBERTO | 1 | 59.7% | +46.3% |
| ZINGARELLI, SANDRA | 1 | 6.7% | +46.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17758181 | Protein Separation | ZINGARELLI, SANDRA | 121d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17758181 | Protein Separation | ZINGARELLI, SANDRA | 121d overdue |
| 18039036 | A METHOD FOR REMOVING A BIOFILM | GONZALEZ, LUISALBERTO | — |
| Art Unit | Apps |
|---|---|
| 1624 | 1 |
| 1653 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18039036 | A METHOD FOR REMOVING A BIOFILM | GONZALEZ, LUISALBERTO | 1624 | §112 | Non-Final OA | — | Pending | May 26, 2023 |
| 17758181 | Protein Separation | ZINGARELLI, SANDRA | 1653 | §103§112 | Non-Final OA | 121d overdue | Pending | Jun 29, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialTechnological University Dublin has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Luisalberto Gonzalez has the most, with 1 of Technological University Dublin's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
